G Hoerni-Simon
Overview
Explore the profile of G Hoerni-Simon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
47
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eghbali H, Petorin C, de Mascarel I, Trojani M, Hoerni-Simon G, Soubeyran P, et al.
Bull Cancer
. 1994 Oct;
81(10):866-70.
PMID: 7734769
The pathological material of 35 patients with Hodgkin's disease lymphocyte-depletion type (type 4) is reviewed with an immunohistochemistry study on paraffin-embedded sections. The new pathologic data are compared with clinical...
2.
Ravaud A, Eghbali H, Trojani M, Hoerni-Simon G, Soubeyran P, Hoerni B
J Clin Oncol
. 1990 Apr;
8(4):608-14.
PMID: 2179478
Between 1973 and 1977, 48 patients less than 65 years old with non-Hodgkin's malignant lymphoma (NHML) of poor prognosis (+/- high grade malignancy, +/- clinical stages III or IV, +/-...
3.
Hoerni B, Ravaud A, Eghbali H, Hoerni-Simon G
Br J Haematol
. 1989 Jan;
71(1):161-2.
PMID: 2644969
No abstract available.
4.
Hoerni B, Sotto J, Eghbali H, Sotto M, Hoerni-Simon G, Pegourie B
Cancer
. 1988 May;
61(10):2057-9.
PMID: 3282641
In two centers (a comprehensive cancer center and a university hospital) 1300 patients with non-Hodgkin's lymphomas (NHL) were observed during the past 15 years. Seventy patients (5.4%) were diagnosed after...
5.
Garraud O, Legrand E, Eghbali H, Hoerni-Simon G, Hoerni B, GUILLEMAIN B
Diagn Clin Immunol
. 1988 Jan;
5(6):417-20.
PMID: 3265363
Proliferation and differentiation of B cells can be promoted by a number of inducing factors, including interleukin-2 (IL-2). In vitro-stimulated normal B cells usually express IL-2 receptors (TAC). Furthermore, it...
6.
Garraud O, Hoerni-Simon G, Legrand E
Diagn Clin Immunol
. 1988 Jan;
5(5):276.
PMID: 3258796
No abstract available.
7.
Hoerni B, Trojani M, Eghbali H, Bonichon F, Coindre J, Garraud O, et al.
Eur J Cancer Clin Oncol
. 1987 Dec;
23(12):1889-93.
PMID: 3436353
A series of 377 low-grade non-Hodgkin's lymphomas, observed in the same Institute, was analysed. Pathological types following the Kiel classification were crossed with the usual parameters of patients (sex, age)...
8.
Hoerni-Simon G, Suchaud J, Eghbali H, Coindre J, Hoerni B
Oncology
. 1987 Jan;
44(2):98-101.
PMID: 3574856
Of 498 patients with non-Hodgkin's lymphoma (NHL), 30 showed secondary central nervous system (CNS) involvement. Of these 30 patients, 26 had high-grade malignancy and 21 lymphoblastic lymphoma, mainly convoluted (n...
9.
Garraud O, Legrand E, Hoerni-Simon G
Arch Pathol Lab Med
. 1987 Jan;
111(1):7.
PMID: 3099727
No abstract available.
10.
Hoerni B, Bonichon F, Coindre J, Garraud O, Eghbali H, Hoerni-Simon G
Bull Cancer
. 1986 Jan;
73(2):171-7.
PMID: 3730636
In this series, the prognosis and the course of 180 cases of follicular lymphomas, classified according to Kiel's classification, seen before any treatment, treated and followed in the same institution...